Visby Medical, a leader in rapid, at-home polymerase chain reaction (PCR) diagnostics, announced it has raised approximately $55 million, with the potential to reach $65 million, in its latest ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Today, Visby Medical announced two new relationships that will expand national access to the Visby Women’s Sexual Health Test, the first, at-home, FDA-authorized PCR ...

SAN JOSE, Calif., March 28, 2025 /PRNewswire/ -- Today, Visby Medical™, a leading innovator in medical diagnostics, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo ...

The Visby Medical Flu and COVID-19 Test Combines Lab-Quality Sensitivity with Immediate Telehealth Connection Visby Medical, the at-home diagnostics company, today announced U.S. Food and Drug ...

PCR is a mainstay in diagnostics, but whether a sample is collected at a clinic or at home, such tests require sending a sample to a lab and then waiting for results. A new FDA authorized ...

The palm-sized Women’s Sexual Health PCR test delivers lab-quality results in 30 minutes via Visby’s mobile app. Patients who test positive are referred to Wisp and receive a complimentary virtual ...

PCR processes are the diagnostic gold standard when it comes to identifying coronavirus infections. Unlike rapid antigen tests, they function even in the case of a low viral load and detect the ...

Promising new inroads into critical DNA testing has been forecast by Flinders University experts who have applied machine learning to DNA profiling. From medical diagnostics to forensic tests and ...

When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years, digital PCR (dPCR) has captured the attention of researchers and clinicians ...

In a recent study posted to the medRxiv* preprint server, researchers examined sample collection practices, epidemiological characteristics, and cycle threshold (Ct) values for polymerase chain ...